William Blair & Company’s Antares Pharma, Inc. ATRS Stock Holding History

William Blair & Company’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-275,000	Closed	-$1.13M	–	1967
2022 Q1	$1.13M	Hold	275,000	–	–	﹤0.01%	876
2021 Q4	$982K	Buy	+275,000	New	+$962K	﹤0.01%	968

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

William Blair & Company's ATRS Position: Q2 2022 in Review

William Blair & Company sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 275,000 shares — an estimated $1.13M sold.

William Blair & Company first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $1.13M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

William Blair & Company reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
William Blair & Company sold 275,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.13M.
William Blair & Company first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
William Blair & Company's Antares Pharma, Inc. position peaked at $1.13M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on William Blair & Company's 13F filing for Q2 2022, filed 10 Aug 2022.